Wealth Enhancement Advisory Services LLC Purchases 5,036 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Wealth Enhancement Advisory Services LLC lifted its holdings in The Cooper Companies, Inc. (NASDAQ:COOFree Report) by 319.3% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 6,613 shares of the medical device company’s stock after purchasing an additional 5,036 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Cooper Companies were worth $671,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Blue Trust Inc. raised its stake in shares of Cooper Companies by 54.8% in the fourth quarter. Blue Trust Inc. now owns 96 shares of the medical device company’s stock worth $36,000 after buying an additional 34 shares during the period. Lindbrook Capital LLC raised its stake in Cooper Companies by 182.5% during the 4th quarter. Lindbrook Capital LLC now owns 113 shares of the medical device company’s stock worth $43,000 after acquiring an additional 73 shares during the period. Desjardins Global Asset Management Inc. lifted its holdings in Cooper Companies by 44.8% during the fourth quarter. Desjardins Global Asset Management Inc. now owns 152 shares of the medical device company’s stock valued at $58,000 after purchasing an additional 47 shares in the last quarter. Venturi Wealth Management LLC boosted its position in shares of Cooper Companies by 30.4% in the fourth quarter. Venturi Wealth Management LLC now owns 180 shares of the medical device company’s stock worth $68,000 after purchasing an additional 42 shares during the period. Finally, Livforsakringsbolaget Skandia Omsesidigt increased its stake in shares of Cooper Companies by 123.0% in the fourth quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 223 shares of the medical device company’s stock worth $84,000 after purchasing an additional 123 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on COO. JPMorgan Chase & Co. raised shares of Cooper Companies from a “neutral” rating to an “overweight” rating and upped their target price for the stock from $100.00 to $120.00 in a report on Wednesday, March 13th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Friday, May 31st. Robert W. Baird raised their target price on shares of Cooper Companies from $116.00 to $118.00 and gave the company an “outperform” rating in a research note on Friday, May 31st. Redburn Atlantic upgraded shares of Cooper Companies from a “neutral” rating to a “buy” rating and set a $125.00 price target on the stock in a research note on Tuesday, March 19th. Finally, Piper Sandler restated an “overweight” rating and set a $115.00 price target on shares of Cooper Companies in a report on Wednesday, July 3rd. Four investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $111.42.

Read Our Latest Stock Report on COO

Cooper Companies Stock Up 0.0 %

Cooper Companies stock opened at $85.68 on Wednesday. The business has a fifty day moving average price of $92.16 and a 200-day moving average price of $94.56. The Cooper Companies, Inc. has a 1-year low of $75.93 and a 1-year high of $104.07. The stock has a market capitalization of $17.06 billion, a price-to-earnings ratio of 50.33, a PEG ratio of 2.13 and a beta of 0.98. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.95 and a quick ratio of 1.14.

Cooper Companies (NASDAQ:COOGet Free Report) last posted its quarterly earnings results on Thursday, May 30th. The medical device company reported $0.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.83 by $0.02. Cooper Companies had a net margin of 9.11% and a return on equity of 8.87%. The business had revenue of $942.60 million during the quarter, compared to analysts’ expectations of $948.07 million. During the same quarter last year, the company posted $0.77 earnings per share. The business’s quarterly revenue was up 7.4% on a year-over-year basis. Equities research analysts forecast that The Cooper Companies, Inc. will post 3.57 EPS for the current fiscal year.

Cooper Companies Company Profile

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Further Reading

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.